Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
191,928,422
-
Total 13F shares
-
17,711,768
-
Share change
-
-666,080
-
Total reported value
-
$73,144,106
-
Put/Call ratio
-
137%
-
Price per share
-
$4.13
-
Number of holders
-
47
-
Value change
-
-$3,356,008
-
Number of buys
-
21
-
Number of sells
-
24
Institutional Holders of Arbutus Biopharma Corp - Common Shares (ABUS) as of Q1 2016
As of 31 Mar 2016,
Arbutus Biopharma Corp - Common Shares (ABUS) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,711,768 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Falcon Edge Capital LP, HealthCor Management, L.P., D. E. Shaw & Co., Inc., SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, AXA, GOLDMAN SACHS GROUP INC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.